Achtung! Das Lehrangebot ist noch nicht vollständig und wird bis Semesterbeginn laufend ergänzt.
322055 VU Radiopharmazie - M14 (2025S)
Prüfungsimmanente Lehrveranstaltung
Labels
An/Abmeldung
Hinweis: Ihr Anmeldezeitpunkt innerhalb der Frist hat keine Auswirkungen auf die Platzvergabe (kein "first come, first served").
- Anmeldung von Mo 10.02.2025 08:00 bis Fr 14.03.2025 20:00
- Abmeldung bis Fr 14.03.2025 20:00
Details
Sprache: Deutsch
Lehrende
Termine
the lecture will be held as block course.
3 afternoons of 4 hours, dates will be announced soon
Grading: continous participation, multi-choice exam (on the last date)
28. März 2025 13-17 Uhr - Seminar room 2E411
11. April 2025 13-17 Uhr - Seminar room 2E411
Information
Ziele, Inhalte und Methode der Lehrveranstaltung
Art der Leistungskontrolle und erlaubte Hilfsmittel
Grading: continuous participation, multiple-choice exam
Mindestanforderungen und Beurteilungsmaßstab
Prüfungsstoff
The exam will be based on the documents and power point presentations as provided on the moodle platform
Literatur
Zuordnung im Vorlesungsverzeichnis
MA23
Letzte Änderung: Mo 10.02.2025 11:07
Radioactive Decay and their Application for Diagnostics and Therapy, Radionuclide Production in a Medical Context, Ideal Properties of Radiopharmaceuticals, Radiobiology and Radiation Safety
2) Approved radiopharmaceuticals for SPECT and Therapy
Overview on approved radiopharmaceuticals for SPECT and their mode of action
3) Approved radiopharmaceuticals for PET and Therapy
Overview on approved radiopharmaceuticals for PET and their mode of action
4) Dosage forms, pharmaceutical packaging of radiopharmaceuticals
Radiopharmaceutical aspects including dosage forms, dose definition for diagnostics and therapeutics, dosimetry, and the respective labeling and packaging for radiopharmaceuticals
5) Formulation and role of excipients in parenteral radiopharmaceutical preparations
Overview, importance and regulatory on excipients in radiopharmaceuticals
6) Module-to-kit development
Aspects of pharmaceutical technology for the module-to-kit development
7) Requirements for radiopharmaceutical quality control
Exercise on quality control and time-efficency
8) Quality assurance, SOPs, Good Manufacturing Practice of Radiopharmaceuticals, Radiopharmaceuticals and the European Pharmacopoeia